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Abstract The female advantage in life expectancy (LE)
is found worldwide, despite differences in living condi-
tions, the status of women and other factors. However, this
advantage has decreased in recent years in low-mortality
countries. Few researchers have looked at the gender gap in
LE in old age (age 65) in a longer historical perspective.
Have women always had an advantage in LE at old age and
do different countries share the same trends? Life expec-
tancy data for 17 countries were assessed from Human
Mortality Database from 1751 to 2007. Since most of the
changes in LE taking place today are driven by reductions
of old age mortality the gender difference in LE was cal-
culated at age 65. Most low-mortality countries show the
same historical trend, a rise and fall of women’s advantage
in LE at age 65. Three phases that all but two countries
passed through were discerned. After a long phase with a
female advantage in LE at 65 of \1 year, the gender gap
increased significantly during the twentieth century. The
increase occurred in all countries but at different time
points. Some countries such as England and France had an
early rise in female advantage (1900–1919), while it
occurred 50 years later in Sweden, Norway and in the
Netherlands. The rise was followed by a more simulta-
neous fall in female advantage in the studied countries
towards the end of the century, with exceptions of Japan
and Spain. The different timing regarding the increase of
women’s advantage indicates that country-specific factors
may have driven the rise in female advantage, while factors
shared by all countries may underlie the simultaneous fall.
More comprehensive, multi-disciplinary study of the evo-
lution of the gender gap in old age could provide new
hypotheses concerning the determinants of gendered dif-
ferences in mortality.
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Introduction
During the last 160 years, the record life expectancy (LE)
at birth has increased at a steady pace (Oeppen and Vaupel
2002). Most gains in LE during this time have been
achieved by reducing mortality at younger ages. It is only
in the last five decades that reductions in old age mortality
have had an impact on life expectancy at birth (Wilmoth
et al. 2000; Oeppen and Vaupel 2002). During the same
time the gender differences in life expectancy at birth
grew for the most part of the twentieth century, but started
to decline around the 1980s in Western countries
(Oksuzyan et al. 2010).
Although there is remarkable variation in LE between
different parts of the world, two similarities are shared: (1)
both women and men show general increases in LE in most
countries (Leon 2011), and (2) women outlive men in all
countries (Barford et al. 2006). The female advantage is
found worldwide, despite differences in living conditions,
the status of women and other factors. In most low-mor-
tality countries, the female advantage in life expectancy
has been narrowing since the 1970s (Mesle´ 2004). Possible
explanations for the decreasing gender difference in LE
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have been suggested and discussed in many countries; most
frequently highlighting the changing smoking patterns
among men and women (see e.g. Nilsson and Simonsson
2009). Discussions have commonly been country specific,
few attempts for international comparisons have been made
(Waldron 1993; Trovato and Heyen 2006; Glei and
Horiuchi 2007; Mesle´ 2004). Since vital statistics are col-
lected nationally, most researchers have focused on
domestic-based differences and few researchers have
studied the gender gap over a longer period of time.
A female advantage in longevity is also widespread
among animals (Austad 2006), although it is far from uni-
versal (Austad 2011). Sex differences in LE can arise as a
result of biological (intrinsic) factors, such as genetic and
physiological advantages. They can also arise from contex-
tual (extrinsic) factors, such as environmental and behav-
ioural factors (Kirkwood and Austad 2000; Gems and Riddle
2000; McCulloch and Gems 2003); often to males’ disad-
vantage (Bonduriansky et al. 2008). Extrinsic and intrinsic
factors are likely to interact in their influence on LE.
Most historical analyses of LE are based on life
expectancy at birth and less is known about the develop-
ment of the gender gap in old age mortality over time. The
focus of this study is the gender gap in life expectancy at
age 65. Focusing on remaining LE at 65 minimises some of
the extrinsic factors related to mortality in younger ages,
such as differential infant mortality risks, obstetrical mor-
tality among women, and risk-taking behaviour and
exposure to hazardous working conditions among men.
Using LE at 65 also reduces the impact of different national
figures regarding high alcohol consumption and smoking
among younger men (Nusselder et al. 2010).
This paper focuses on the gender gap in LE at age 65 in
a historical and global perspective. The first objective of
this study is to describe gender differences in human lon-
gevity using vital statistics from different countries over an
extended period of time. Sweden is the country with the
oldest vital statistics in the world (starting in 1751). Thus,
we begin by presenting the development of life expectancy
for women and men at age 65 in Sweden from 1751 until
2007. Then, gender differences in LE for 17 countries with
data prior to 1950 are given. By focusing on similarities
among countries, our aim is to display a more complete
picture of how gender differences in life expectancy have
developed in a historical and global perspective. Have
women always had an advantage in LE? Have there been
changes over time in the LE gender gap? Have these
changes been similar in all countries? Using extended time
series, we can identify historical fluctuations in the gender
gap in the different countries to search for similarities and
differences in the fluctuations over time.
The second objective of this study is to discuss these LE
fluctuations in relation to historical trends in other gender-
related factors (given lag effects) such as smoking, access
to education, warfare mortality and working conditions.
In light of what is known about the cultural, social and
biological factors related to sex differences in aging,
gender gap trends in LE can contribute to the generation
of hypotheses about underlying gender-related LE
determinants.
Materials and methods
The Human Mortality Database (HMD) (Human Mortality
Database Date accessed: February 10, 2010) is a collabo-
rative project, launched in 2002, involving research teams
at the Department of Demography at the University of
California, Berkeley (USA) and at the Max Planck Institute
for Demographic Research (MPIDR) in Rostock (Germany).
It contains death rates and life tables for national populations
(countries or areas), as well as the input data used in con-
structing those tables. The input data consist of death counts
from vital statistics, plus census counts, birth counts, and
population estimates from various sources. The data for LE
65 is calculated in a comparable way for all included coun-
tries. The data quality is generally good, however, data col-
lected prior to 1950 can be affected by methodological issues
and should be regarded with higher caution.
All countries with data prior to 1950 and without meth-
odological issues (after 1950) according to HMD, were
selected for this study. Iceland was excluded since data
fluctuated considerably due to its small population. Since
only countries with data prior to 1950 were included in the
sample, the included countries were those with a long tra-
dition of keeping birth and death counts. These countries are
today generally countries of relative affluence and low-
mortality (LE at 65 ranges from 84 to 88 years for women
and 81 to 83 years for men in 2000–2007). Seventeen
countries were included in the study: Sweden (SWE), United
States (US), England and Wales (ENG and W), France
(FRA), Japan (JPN), Finland (FIN), Denmark (DNK), Italy
(ITA), Norway (NOR), the Netherlands (NLD), Canada
(CAN), Belgium (BEL), Switzerland (CHE), Australia
(AUS), Spain (ESP), New Zealand (NZL) and Austria
(AUT). The earliest available statistics are from 1751
(Sweden) and the latest from 1948 (New Zealand).
Life expectancy is an estimate of the number of years a
person can expect to live under the mortality conditions of
that specific year. We report the gender differences in LE at
65 (delta LE at 65) in absolute numbers (actual years) since
we do not want to give larger impact to smaller numbers.
For example, a 1-year difference would have looked larger
(in ratios) in the beginning of the study period, when life
expectancy was lower than in more recent years when life
expectancy has increased.
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Results
Figure 1 presents remaining life expectancy at age 65 for men
and women in Sweden, from 1751 until 2007. The graph
shows that from the mid eighteenth century and into the
nineteenth, women had a remaining LE at 65 of about 11 years
and men about 10 years. In the 1840s, LE began to increase for
both men and women and has continued to rise ever since. In
2007, LE at 65 was 20 years for women and 17 years for men.
Focusing on the gender differences in LE in Fig. 1, three
phases can be discerned. During 200 years, women’s advan-
tage was stable at\1 year (Phase A). In the 1950s, the gender
gap began to increase beyond the 1-year gap (Phase B), mainly
due to LE improvements among women. In the 1970s, the gap
began to diminish (Phase C) as men’s survival improved.
Figure 2 depicts the gender differences in LE at age 65
in different countries during the last centuries. As in
Sweden, all included countries show a progression from a
period with a slight advantage for women (Phase A), to a
rapid increase in women’s advantage (Phase B), followed
by a decrease in the gender gap (Phase C). All countries
seem to pass through all phases, with the exceptions of
Japan and Spain that did not show a decrease (Phase C).
The years of entrance into Phases B and C differ between
countries (the shaded areas in Fig. 2).
Phase A is characterized by a women’s advantage of
\1 year. During this period, chances of surviving to advanced
ages were low. In Sweden, for example, the probability of
surviving to age 65 was 23 % among men and 29 % among
women in 1751, and 49 and 54 %, respectively, around 1900.
During Phase B, women’s advantage in LE increased.
From a stable difference of about 1 year, LE for men and
women diverges in all represented countries and reaches a
discrepancy of about 4 years around the 1980s. However,
the onset of the rise varies considerably between the
countries, as seen in the shaded area in Phase B in Fig. 2.
The first countries to enter Phase B are England, France
and Finland around the turn of the twentieth century,
whereas Sweden and the Netherlands enter more than
50 years later. In countries with later debuts, women’s
advantage increased at a faster rate, so that all countries
reached a 4-year gender gap at about the same time.
Phase C is distinguished by another trend shift: the rise
in gender differences ends abruptly and within a period of
20 years (approximately 1970–1990), women’s advantage
in longevity decreases in all included countries except
Japan and Spain. The curve for Spain levels off, while the
advantage for Japanese women continues to rise.
The probability to survive to age 65 continued to increase
during Phases B and C. In Sweden, 62 % of men and 67 % of
women survived from birth to age 65 in the year 1930–1939.
In 1980–1989, the rates were 79 and 89 %, respectively.
Discussion
The pattern of change in gender differences in LE at 65 is
remarkably similar over time in the studied low-mortality
countries. Three phases could be identified in all countries,
with two exceptions. Until the twentieth century, the
Fig. 1 Remaining life
expectancy (LE) at age 65 for
men and women in Sweden,
1751–2007
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included countries had a gender difference of 1 year or less
in favour of women (Phase A). This was followed by a
period with differences increasing to about 4 years (Phase
B). In most countries, the peak was seen during the
1970–1980s. Since the 1980s, the gender difference in LE
at 65 has been decreasing in all of the studied countries
(Phase C) except Japan and Spain. However, recent data
suggests that the gender gap in Japan has also begun to
decrease (Liu et al. 2012a).
We find it noteworthy that most of the countries, that are
considered low-mortality countries today, share a common
development in LE, although historically they have had
different experiences of war, urbanisation, welfare systems,
industrialisation and migration. Countries also show simi-
lar patterns of LE gender differences, despite differences in
gender roles and opportunities for women.
Furthermore, it is intriguing that although most coun-
tries share the same trends, the timing of the phases differs
between the countries. The first trend shift—the increase of
the gender difference—occurred over a period of 50 years
starting with England and France. The shift came much
later in Sweden, Norway and the Netherlands. On the other
hand, the more recent narrowing of gender differences
happened over a much shorter time.
Studying this inter-country variability—and similarity—
can help to identify possible mechanisms driving the
changes in the LE gender gap. These long-term trends in
LE can be put in a historical context. In the eighteenth and
nineteenth centuries, mortality rates were high due to
extrinsic factors, such as epidemics and adverse living
conditions. Less than half of the population survived to
65 years of age. Historically, this was a period of relatively
low economic growth in many of the countries. Women’s
advantage in LE was stable over time at about 1 year
(Phase A).
The twentieth century was characterised by exceptional
economic growth, industrialisation and urbanisation as well
as medical advances in many countries. Attempts to
explain the widening of the longevity gender gap (Phase B)
have primarily been nationally based and have focused on
environmental and societal factors. Industrialisation and
urbanisation have been suggested to be more favourable for
women, e.g. due to men’s adverse working conditions and
poorer health habits (Mooney 2002). Women’s suffrage,
entrance into the labour market, and safer child bearing
also favoured women (Nobles et al. 2010; Pampel and
Zimmer 1989). Although these factors primarily influence
mortality in younger ages, they also affect the chance to
reach old age as well as longevity in old age.
An alternative interpretation is that the widening gender
gap in Phase B is an indication of a biological female
longevity advantage. If mortality is largely driven by social
factors at younger ages, does biology take a larger toll at
old age? From an evolutionary perspective, extrinsic fac-
tors are the most important determinants of survival in a
population. In a society with a high level of extrinsic
hazards, distributed equally, women and men will have a
low and similar LE (as in Phase A). Those who escape the
hazards of extrinsic mortality face the effects of the aging
process, i.e. cellular, DNA, tissue and organ damage which
the body is unable to repair (Kirkwood and Austad 2000;
Kirkwood 2005), ultimately leading to intrinsic (or age-
related) mortality. As extrinsic hazards level off, intrinsic
rather than extrinsic mortality begins to take a toll, possibly
Fig. 2 Gender difference in life
expectancy (LE) at age 65
(in years) in 17 countries,
1751–2007
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revealing a biological longevity advantage of women. An
array of hypotheses has been proposed to explain why
females could have an advantage, e.g. oestrogen levels,
oxidative stress and reproduction (Oksuzyan et al. 2008;
Kirkwood 2001).
However, if increases in LE were to unmask a biological
advantage in women, countries with an increasing LE
should also show an increasing gender gap as extrinsic
mortality decreases and more people reach 65. Demo-
graphic data, however, do not support this. While proba-
bilities to survive to age 65 increased remarkably during
the early twentieth century, a higher survival to age 65 did
not necessarily prelude increasing gender differences in
LE. On the contrary, the first countries to show rising
gender differences had lower probabilities of reaching 65
than the late risers. In 1900, when the gender gap began to
rise in France, England and Finland, chances of surviving
to age 65 ranged between 36–38 % for men and 43–46 %
for women; while the Netherlands, Sweden and Norway
had probabilities of 46–49 % for men and 50–54 % for
women to survive to age 65 in the same year. In 1950,
similar inter-country differences in the probability of sur-
viving to age 65 remained. Therefore, a biological female
advantage cannot be the only explanation for the increase
in the LE gender gap. Nor can it explain the more recent
decrease in the gender gap.
The increasing gender difference came to a remarkably
simultaneous halt between 1970 and 1990 in almost all
studied countries, followed by a decrease (Phase C) that is
still ongoing (Waldron 1993; Trovato and Heyen 2006;
Glei and Horiuchi 2007). While entrance into Phase B
showed wide variations between countries, entrance into
Phase C occurred during a narrower time margin. This
period is characterised by further improvements in living
conditions and continued increases in LE driven mainly by
reduced mortality in old age (Vaupel 2010; Wilmoth et al.
2000). Also, from the 1970s and onward the timing of
demographic events, such as mortality trends, seems to
have become more similar across countries (Leon 2011).
However, two countries have not yet entered Phase C,
Japan and Spain. One reason suggested for the increasing
gender inequality in Japan is respiratory diseases. At very
high ages, Japanese women’s rate of respiratory disease is
stable whereas it is increasing among men (Mesle´ 2004).
In most countries, the reduced gap is related to increased
LE gains among men rather than losses among women
(Mesle´ 2004; Meinow et al. 2010). A cross-national com-
parison showed that the narrowing of the female advantage
was mainly due to reductions in cardiovascular mortality
among men in the Nordic countries, England and Wales,
whereas the narrowing of the gap in the Mediterranean
countries was mainly due to reductions in male cancer
mortality (Mesle´ 2004). Reductions in cardiovascular
mortality are often attributed to both medical advances and
improved lifestyle habits (Rose´n and Haglund 2005). The
medical and technical advances, especially those relating to
cardiovascular health and mortality, may have favoured
survival among older men to a greater extent than older
women (Rose´n and Haglund 2005). Also, lifestyle habits
have gradually become more similar among men and
women during this period, e.g. men have quit smoking to a
large extent while women have taken up the habit (Lopez
et al. 1994).
In Sweden, as elsewhere, a common hypothesis has been
that the changes in smoking habits over time—initially a
male habit gradually becoming a female habit, explain both
the widening (Phase B) and the narrowing of the gap
(Phase C). Although smoking probably has played an
important explanatory role for the changes in gender dif-
ference in LE in some of the studied countries (Mesle´ and
Vallin 2006), smoking does not account for the total gender
difference in LE (McCartney et al. 2011). Further, from a
cross-national perspective, the gap emerged too early in
some countries (England, France and Finland) to be a
consequence of increased male smoking habits (Ravenholt
1990).
Many questions remain. Will LE continue to rise for
both women and men during the coming centuries? The
prediction that 50 % of all children born in England and the
US in the beginning of this millennium will live to be a
100 years old (Christensen et al. 2009) rests on a number of
assumptions (e.g. unchanged mortality rates before age 50
and continued improvements in mortality rates in old age)
that have been questioned by others (Olshansky and Carnes
2010). Will the gender gap in LE continue to decrease?
According to our own calculations, the longevity gender
gap in Sweden will be eliminated by the middle of
this century, if the current rate of decrease continues
(Lagergren; calculations not shown) or will the gap
increase once again as smoking-related mortality levels off
among women, allowing the hypothesised female biologi-
cal advantage to re-emerge (Pampel 2002)?
This paper focuses on general similarities between
countries in the development of sex differences in LE at
age 65. Many aspects of life expectancy remain to be
further investigated, e.g. probabilities to survive to
65 years. When investigating the mechanisms behind life
expectancy in old age it is important to take into account
that the increasing proportion of people surviving to old
age in a population, most likely leads to a weaker selective
survival. More study of selective survival, and how this can
affect gender differences in LE, are called for.
Another factor to consider is the fact that men have had
greater variation in age at death compared to women. Over
time, men’s deaths have compressed to a narrower age
range and their survivorship has become more rectangular,
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similar to women’s. Glei and Horiuchi (2007) explain that
this could have contributed to the decreased gender gap in
LE (Phase C). However, it does not fully account for the
reduction of the gender gap.
The study of populations over time is complex. Life
expectancy differences should ideally be studied in relation
to country-level differences. The risk of ‘‘ecological fal-
lacy,’’ whereby inferences about individuals are based on
aggregate data, is obvious in the study of population-level
determinants of gender differences. However, studying
gender differences across countries in relation to macro-
level structural indicators could be a useful method for
understanding and generating new hypotheses about gender
differences in old age. For example, in the European
Union, Van Oyen et al. (2010) have shown that gender
differences in activity limitations are affected by macro-
level indicators such as: gross domestic product, expendi-
ture on elder care and income inequality in recent years. An
analysis of OECD countries showed a negative association
between the gender gap in LE and country-specific social
development indices (Liu et al. 2012b). Further research is
needed to understand how these factors have influenced the
gender gap in LE and the transitions between Phases A, B
and C. From a historical perspective, many factors seem
well worth studying in relation to gender differences in
mortality: economic growth, urbanisation and industriali-
sation, the experience of war and the expansion of welfare
institutions such as public schools, pension systems and
health care systems.
Vital statistics provide the ‘big picture’ that can chal-
lenge assumptions and generate hypotheses about how
political, social and economic change, along with health
behaviours such as smoking, alcohol consumption and
obesity, contribute to changes in LE (Leon 2011). Like-
wise, they reflect how changes in living conditions and
social roles can affect men and women differently, as seen
in the gender gap in LE. The concept of the three phases of
the LE gender gap outlined here can be used as a frame-
work on which further work can be based. By comparing
trends in, e.g. gender differentiated behaviour or living
conditions, against the trends in the LE gender gap in the
different countries, we may be able to identify factors that
impact LE differently for men and women. For example,
the timing of change in smoking behaviour among women
and men was different in different countries. Is this timing
(accounting for a possible lag effect) associated with
entrance into Phase B (the increase in LE gender gap)? Of
particular interest would be to investigate factors associ-
ated with entrance into Phase C—a transition that occurs
almost simultaneously in all countries except two. Do the
latter factors represent some aspect of globalisation among
low-mortality countries? Which of these factors are
potentially modifiable?
Investigating gender differences in LE can ultimately
advance understanding of the intertwined and synergistic
processes determining longevity. Despite decades of
research, the role of behavioural, biological and social
factors in gender differences in LE remain confusing if not
elusive. Change in the LE gender gap cannot be understood
in the context of a single country or a single discipline. The
multifaceted nature of demographic and socioeconomic
change calls for a broad multidisciplinary approach when
analysing differences (and similarities) between countries
and populations over time. Demographers and epidemiol-
ogists need to collaborate with historians and social sci-
entists as well as with biologists and medical scientists if
we are to understand the forces driving longevity.
In conclusion, our findings indicate that the studied
countries have shown similar patterns in the LE gender gap
at age 65, but with different timing. However, the timing of
gender gap change seems to have become more similar
over time, which could indicate that the factors driving LE
gender differences in old age have become increasingly
international. More international and historical investiga-
tion of the trends identified in this study could provide new
hypotheses for research and better understanding of the
gender gap in old age mortality.
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